316 related articles for article (PubMed ID: 20132965)
1. Serum procalcitonin in systemic autoimmune diseases--where are we now?
Buhaescu I; Yood RA; Izzedine H
Semin Arthritis Rheum; 2010 Oct; 40(2):176-83. PubMed ID: 20132965
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of procalcitonin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection.
Eberhard OK; Haubitz M; Brunkhorst FM; Kliem V; Koch KM; Brunkhorst R
Arthritis Rheum; 1997 Jul; 40(7):1250-6. PubMed ID: 9214425
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of serum procalcitonin concentrations for detecting systemic bacterial infection in patients with systemic autoimmune diseases.
Tamaki K; Kogata Y; Sugiyama D; Nakazawa T; Hatachi S; Kageyama G; Nishimura K; Morinobu A; Kumagai S
J Rheumatol; 2008 Jan; 35(1):114-9. PubMed ID: 18050369
[TBL] [Abstract][Full Text] [Related]
4. Procalcitonin for discrimination between activity of systemic autoimmune disease and systemic bacterial infection.
Brunkhorst R; Eberhardt OK; Haubitz M; Brunkhorst FM
Intensive Care Med; 2000 Mar; 26 Suppl 2():S199-201. PubMed ID: 18470720
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases.
Scirè CA; Cavagna L; Perotti C; Bruschi E; Caporali R; Montecucco C
Clin Exp Rheumatol; 2006; 24(2):123-8. PubMed ID: 16762145
[TBL] [Abstract][Full Text] [Related]
6. CRP levels in autoimmune disease can be specified by measurement of procalcitonin.
Schwenger V; Sis J; Breitbart A; Andrassy K
Infection; 1998; 26(5):274-6. PubMed ID: 9795783
[TBL] [Abstract][Full Text] [Related]
7. Differential diagnosis of bacterial infection and inflammatory response in kidney diseases using procalcitonin.
Sitter T; Schmidt M; Schneider S; Schiffl H
J Nephrol; 2002; 15(3):297-301. PubMed ID: 12113602
[TBL] [Abstract][Full Text] [Related]
8. Serum procalcitonin levels in patients with myeloperoxidase-antineutrophil cytoplasmic antibodies-associated glomerulonephritis.
Komatsuda A; Omokawa A; Fujiwara T; Sato R; Togashi M; Okuyama S; Sawada KI; Wakui H
Am J Med Sci; 2012 Feb; 343(2):136-140. PubMed ID: 21817883
[TBL] [Abstract][Full Text] [Related]
9. Is serum procalcitonin measurement a useful addition to a rheumatologist's repertoire? A review of its diagnostic role in systemic inflammatory diseases and joint infections.
Shaikh MM; Hermans LE; van Laar JM
Rheumatology (Oxford); 2015 Feb; 54(2):231-40. PubMed ID: 25349443
[TBL] [Abstract][Full Text] [Related]
10. The use of procalcitonin determinations in evaluation of systemic lupus erythematosus.
Quintana G; Medina YF; Rojas C; Fernandez A; Restrepo JF; Rondon F; Iglesias A
J Clin Rheumatol; 2008 Jun; 14(3):138-42. PubMed ID: 18525431
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of serum procalcitonin measurement in the diagnosis of bacterial infection in patients with systemic autoimmune diseases].
Takajo I; Yamamoto I; Umeki K; Okayama A
Rinsho Byori; 2012 Apr; 60(4):294-9. PubMed ID: 22686037
[TBL] [Abstract][Full Text] [Related]
12. Serum procalcitonin does not differentiate between infection and disease flare in patients with systemic lupus erythematosus.
Lanoix JP; Bourgeois AM; Schmidt J; Desblache J; Salle V; Smail A; Mazière JC; Betsou F; Choukroun G; Duhaut P; Ducroix JP
Lupus; 2011 Feb; 20(2):125-30. PubMed ID: 20937623
[TBL] [Abstract][Full Text] [Related]
13. Serum procalcitonin and C-reactive protein for differentiating bacterial infection from disease activity in patients with systemic lupus erythematosus.
Yu J; Xu B; Huang Y; Zhao J; Wang S; Wang H; Yang N
Mod Rheumatol; 2014 May; 24(3):457-63. PubMed ID: 24252006
[TBL] [Abstract][Full Text] [Related]
14. [Plasma procalcitonin in rheumatic diseases].
Scirè CA; Caporali R; Perotti C; Montecucco C
Reumatismo; 2003; 55(2):113-8. PubMed ID: 12874646
[TBL] [Abstract][Full Text] [Related]
15. Serum procalcitonin has negative predictive value for bacterial infection in active systemic lupus erythematosus.
Bador KM; Intan S; Hussin S; Gafor AH
Lupus; 2012 Oct; 21(11):1172-7. PubMed ID: 22652631
[TBL] [Abstract][Full Text] [Related]
16. Prospective Evaluation of Procalcitonin, Soluble Triggering Receptor Expressed on Myeloid Cells-1 and C-Reactive Protein in Febrile Patients with Autoimmune Diseases.
Lin CH; Hsieh SC; Keng LT; Lee HS; Chang HT; Liao WY; Ho CC; Yu CJ
PLoS One; 2016; 11(4):e0153938. PubMed ID: 27096761
[TBL] [Abstract][Full Text] [Related]
17. Can procalcitonin be used to distinguish between disease flare and infection in patients with systemic lupus erythematosus: a systematic literature review.
Serio I; Arnaud L; Mathian A; Hausfater P; Amoura Z
Clin Rheumatol; 2014 Sep; 33(9):1209-15. PubMed ID: 25064130
[TBL] [Abstract][Full Text] [Related]
18. Detection of procalcitonin (PCT) in healthy controls and patients with local infection by a sensitive ILMA.
Morgenthaler NG; Struck J; Fischer-Schulz C; Seidel-Mueller E; Beier W; Bergmann A
Clin Lab; 2002; 48(5-6):263-70. PubMed ID: 12071576
[TBL] [Abstract][Full Text] [Related]
19. Combining Calcitonin and Procalcitonin and Rheumatoid Arthritis-Related Biomarkers Improve Diagnostic Outcomes in Early Rheumatoid Arthritis.
Liu Y; Shi J; Wang B; Zhou L; Zhou X; Du Y; Li D; Duan L; Hu Q; Chen W; Li P
Dis Markers; 2021; 2021():6331994. PubMed ID: 34136020
[TBL] [Abstract][Full Text] [Related]
20. Procalcitonin and infection in elderly patients.
Stucker F; Herrmann F; Graf JD; Michel JP; Krause KH; Gavazzi G
J Am Geriatr Soc; 2005 Aug; 53(8):1392-5. PubMed ID: 16078967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
